{
    "2019-09-02": [
        [
            {
                "time": "",
                "original_text": "重药控股股东拟混改引入战投 49%股权转让作价41亿元 减持股份",
                "features": {
                    "keywords": [
                        "重药控股",
                        "混改",
                        "战投",
                        "股权转让",
                        "减持"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "带量采购重塑跨国药企专利过期原研药市场",
                "features": {
                    "keywords": [
                        "带量采购",
                        "跨国药企",
                        "专利过期",
                        "原研药"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "一周新股|多家巨头齐递表，复宏汉霖过聆讯",
                "features": {
                    "keywords": [
                        "新股",
                        "复宏汉霖",
                        "聆讯"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "国内首款生物类似药获批上市，复宏汉霖仿创结合打造生物药全产业链",
                "features": {
                    "keywords": [
                        "生物类似药",
                        "复宏汉霖",
                        "仿创结合",
                        "全产业链"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}